Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hemangioma, Cavernous, Central Nervous System × DNA × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Carcinoma 2 Salivary Gland Neoplasms 1 Myelodysplastic Syndromes 1 Lung Neoplasms 1 Hemangioma, Cavernous, Central Nervous System 1 Head and Neck Neoplasms 1 Cytopenia 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Simvastatin 1 Propranolol 1 DNA 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03474614 2024-04-19

Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation

St. Joseph's Hospital and Medical Center, Phoenix

Phase 2 Terminated

Hemangioma, Cavernous, Central Nervous System

Data powered by HemOnc (CC BY 4.0) Colophon ⚡